research – Page 3

AstraZeneca, China sales, biopharma innovation, investment, research and development, healthcare market, pharmaceutical industry, clinical trials, partnerships, collaborations.

Biogen and Ionis Discontinue ALS Drug Development Following Unsuccessful Early Trials

11 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Biogen, Discontinuation (procedure), Drug Development, Early-stage, Ionis, nervous system disorder, research

Biogen, Ionis, ALS, drug development, early-stage trial, disappointing results, discontinuation, neurological disorder, treatment research.

Pharmaceutical Giants Sanofi, Pfizer, and AstraZeneca Pump $1.87 Billion into French Operations

11 months ago talkbio0Tagged AstraZeneca, development aspects, Drug Industry, France, Investments, Manufacture, Pfizer, production, research, sanofi, Surgical aspects, Vaccines

Sanofi, Pfizer, AstraZeneca, France, investment, pharmaceutical industry, operations, vaccine production, research and development, manufacturing.

Novo, Gates, and Wellcome Join Forces with $300 Million Initiative to Tackle Global Infectious Diseases

12 months ago talkbio0Tagged Collaboration, Communicable Diseases, development aspects, Global Health, Holdings, Melinda, Microbicides, pandemic preparedness, research, Resistance (Psychotherapeutic), Trust (Social Behavior), Wellcome

Novo Holdings, Bill & Melinda Gates Foundation, Wellcome Trust, infectious diseases, global health, pandemic preparedness, antimicrobial resistance, research and development, funding, collaboration.

Harmony Pharmaceuticals Expands into Rare Genetic Epilepsies with Acquisition of Epygenix Therapeutics

12 months ago talkbio0Tagged Acquisition (action), CDK-like kinase inhibitors, Collaboration, development aspects, Epygenix, genetic epilepsies, Harmony Pharmaceuticals, Infantile Severe Myoclonic Epilepsy, Mutation, research

Harmony Pharmaceuticals, Epygenix Therapeutics, rare genetic epilepsies, acquisition, treatment, research, development, collaboration, genetic mutations, Dravet syndrome, CDK-like kinase inhibitors

Revolutionizing Research and Development: Xaira Unveils AI-Driven Platform with $1B Funding and Former Genentech Leaders

1 year ago talkbio0Tagged AI-Powered Xaira, Artificial Intelligence, Biotechnology, cell transformation, Genentech executives, innovation, R&D, research, Surgical advancement - action

AI-Powered Xaira, $1B funding, Genentech executives, R&D transformation, biotechnology innovation, artificial intelligence in research, life sciences advancement.

BenevolentAI Downsizes Operations, Cuts 30% of Workforce Amidst Funding Challenges

1 year ago talkbio0Tagged AI, Artificial Intelligence, BenevolentAI, Drug Discovery, GTPase-Activating Proteins, research

BenevolentAI, layoffs, workforce reduction, funding gap, US site closure, AI research, drug discovery